监管框架,挑战和先进治疗产品 (PTA) 开发在巴西的初始战略规划
Flávia Nathiely Silveira Fachel1,2, Roselena Silvestri Schuh3,4, Patrícia Bencke Grudzinski3
1Células, Tecidos e Genes (CTG), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, R. Ramiro Barcelos 2350, Porto Alegre, RS, 90035-903, Brazil. flavia.fachel@ufrgs.br.
Therapeutic innovation & regulatory science
|October 10, 2023
概括
本研究概述了包括细胞,组织和基因疗法在内的先进疗法的监管途径,重点关注巴西的指导方针. 它提出了临床前研究的战略框架,以应对制造和临床挑战.
科学领域:
- 生物技术和制药科学 生物技术和制药科学
- 监管科学 监管科学
- 再生医学是一种再生医学.
背景情况:
- 先进的疗法,包括细胞,组织和基因疗法,为复杂疾病提供了新的治疗方法,其替代方案有限.
- 将基础研究转化为经批准的药物需要遵守严格的监管要求.
- 当前的监管环境在制造,产品表征和临床前开发方面存在挑战.
研究的目的:
- 审查和分析对先进疗法的关键监管建议,特别关注巴西法规.
- 确定先进疗法的开发途径中的关键挑战,从制造到临床终点.
- 为规划临床前研究提出战略框架,以促进监管合规.
主要方法:
- 对先进疗法的现有监管指南和建议进行全面审查.
- 分析关键发展阶段:制造,产品表征,非临床试验和终点定义.
- 为临床前研究制定战略规划框架,用基因编辑产品示例说明.
主要成果:
- 确定了先进疗法开发中的重大障碍,包括制造复杂性,产品表征困难和动物模型不足.
- 强调缺乏经过验证的治疗终点是临床翻译的一个主要挑战.
- 提出了一项拟议的框架,以指导先进疗法的战略临床前研究规划.
结论:
- 导航先进疗法的监管途径需要仔细的战略规划,特别是临床前研究.
- 拟议的框架提供了一个结构化的方法来解决制造,表征和临床验证的挑战.
- 所述原则适用于各种先进疗法,包括基因编辑产品.
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Administration and Therapy Phases: Overview
489
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
489
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Drug Control Governance: Regulatory Bodies and Their Impact
165
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
165


